• Proposal for a simple algorithm to differentiate adult-onset Still's disease with other fever of unknown origin causes: a longitudinal prospective study 

      Bilgin, Emre; Hayran, Mutlu; Erden, Abdulsamet; Armağan, Berkan; Sarı, Alper; Kılıç, Levent; Akdoğan, Ali; Karadağ, Ömer; Apraş Bilgen, Şule; Kiraz, Sedat; Ertenli, İhsan; Kalyoncu, Umut (Springer, 2019-02-01)
      Objective: To identify several clinical and/or laboratory parameters which can differentiate adult-onset Still's disease (AOSD) from other causes of fever of unknown origin (FUO) and create a clinician-friendly algorithm ...
    • Some concerns from Turkey 

      Bilgin, Emre; Ozarli, İrem; Kılıc, Levent; Bolek, Ertuğrul Çagrı; Yardımcı, Gözde Kübra; Karadağ, Ömer (BMJ, 2018-11-24)
      We read the paper written by Kaneko et al with great interest.1 This study demonstrates the safety and efficacy of tocilizumab in patients with adult-onset Still’s disease (AOSD). This randomised placebo-controlled study ...